Christina Larkin

2017

In 2017, Christina Larkin earned a total compensation of $1.2M as Chief Operating Officer at Spero Therapeutics, a 200% increase compared to previous year.

Compensation breakdown

Bonus$98,325
Option Awards$796,800
Salary$330,669
Other$734
Total$1,226,528

Larkin received $796.8K in option awards, accounting for 65% of the total pay in 2017.

Larkin also received $98.3K in bonus, $330.7K in salary and $734 in other compensation.

Rankings

In 2017, Christina Larkin's compensation ranked 7,996th out of 14,666 executives tracked by ExecPay. In other words, Larkin earned more than 45.5% of executives.

ClassificationRankingPercentile
All
7,996
out of 14,666
46th
Division
Manufacturing
3,003
out of 5,772
48th
Major group
Chemicals And Allied Products
983
out of 2,075
53rd
Industry group
Drugs
768
out of 1,731
56th
Industry
Pharmaceutical Preparations
605
out of 1,333
55th
Source: SEC filing on April 27, 2018.

Larkin's colleagues

We found three more compensation records of executives who worked with Christina Larkin at Spero Therapeutics in 2017.

2017

Ankit Mahadevia

Spero Therapeutics

Chief Executive Officer

2017

Cristina Larkin

Spero Therapeutics

Chief Operating Officer

2017

Joel Sendek

Spero Therapeutics

Chief Financial Officer

News

In-depth

You may also like